FREE Shipping on all US Orders
From Root to Ritual
Ingredient spotlight: clary sage — sclareol, phytoestrogen activity, sebum regulation, and why this is the most hormonally interesting essential oil for hair.
Clary sage (Salvia sclarea) essential oil contains sclareol — a
diterpene alcohol that mimics oestrogen at the receptor level.
It also contains linalyl acetate (approximately 74%) which regulates
scalp sebum production. No standalone hair RCT exists for clary sage.
Its phytoestrogen activity makes it the most hormonally relevant
essential oil for women experiencing hair loss at hormonal transitions —
perimenopause, postmenopause, post-pill. The anti-inflammatory activity
via linalool and linalyl acetate addresses the PIILIF inflammatory
pathway. Here is the complete honest picture.
The NALU facial mist and cleansing oil: one single-ingredient product, one ten-oil formula — and what they do together as a complete facial ritual opener.
In brief: Two NALU facial products — one with a single ingredient, one with fifteen. The NALU Moisture Bliss Facial Mist is 100% organic rose ger...
Alcohol and hair loss: what a 2024 systematic review and meta-analysis actually found — and the honest distinction between moderate drinking and chronic heavy drinking.
A November 2024 systematic review and meta-analysis (Professor Yun Hak
Kim, Pusan National University, Alcohol and Alcoholism) found that
although individuals who consume alcohol may have a slightly higher
likelihood of experiencing AGA compared to non-drinkers, this
association is not statistically significant. The honest distinction:
moderate drinking (under 14 drinks/week women, 21 men) is not a
well-established direct hair loss cause. Heavy chronic drinking
operates through four real mechanisms — B vitamin depletion, zinc
and iron malabsorption, hormonal disruption, and cortisol elevation.
Here is the complete evidence-based picture.
Ingredient spotlight: black seed oil — thymoquinone, the COX-2/PGD2 mechanism, and the honest evidence picture for a widely promoted natural remedy.
Black seed oil (Nigella sativa) contains thymoquinone — a compound
that inhibits COX-2 and reduces prostaglandin D2 (PGD2), an
inflammatory molecule elevated in balding scalps. A 2014 RCT found
significant improvement in hair density and thickness for telogen
effluvium patients using a topical Nigella sativa lotion vs placebo.
The honest limitation: most other evidence is small, short, or
animal-based. The evidence for AGA specifically is thin. The
anti-inflammatory mechanism is its strongest contribution. Here is
the complete picture.
The $26 million hair growth injectable that started with a hairy mole — Amplifica's osteopontin discovery, the Phase 1 results, and what Eli Lilly's participation signals.
Amplifica Holdings Group closed an oversubscribed $26 million Series B
on August 12, 2026 — with Eli Lilly as a strategic investor. The
science begins with hairy moles: UCI professor Maksim Plikus discovered
that senescent pigment cells in moles produce osteopontin, a signalling
molecule that reactivates dormant hair follicle stem cells. AMP-303
— Amplifica's lead injectable candidate — completed a Phase 1 RCT
(September 2024) showing statistically significant >15% increase in
non-vellus hair count at 60 days (p<0.001) vs placebo. This is early
but genuinely interesting. Here is the complete honest picture.
Post-COVID hair loss: four biological pathways, one clinical picture — and why the long COVID variant is a different problem from the acute infection one.
A 2024 multi-centre cross-sectional study of 500 female COVID-19
patients found 61.4% experienced some form of hair problem after
infection — telogen effluvium accounting for the majority. A
COVID-19 Long Haul Foundation review (May 2026) identified four
biological pathways: cytokine-driven TE, vascular injury to follicle
supply, hypoxic stress from illness severity, and immune privilege
collapse at the hair bulb. Most post-acute COVID hair loss resolves
within 6-9 months without treatment. Long COVID hair loss is a
different and more persistent problem. Here is the complete guide.
When the immune system turns on your hair: autoimmune conditions, hair loss mechanisms, and what a 2025 gut-skin discovery changes about how we investigate alopecia areata.
More than 80 autoimmune diseases exist — and hair loss features in
many of them through five distinct mechanisms: direct follicle attack
(alopecia areata), systemic inflammation-driven TE, hormone disruption
(Hashimoto's, Graves'), medication-induced TE, and scarring from
cutaneous autoimmune lesions (discoid lupus). A paper published
August 25, 2025 in JAAD (University of California, Irvine) found an
unexpected connection between microscopic colitis and alopecia areata —
suggesting the gut-skin axis is more directly relevant to AA than
previously understood. Here is the complete honest guide.
Frontal fibrosing alopecia: the fastest-growing scarring alopecia globally — what it is, why it's increasing, and the sunscreen hypothesis the experts are still debating.
Frontal fibrosing alopecia (FFA) is a progressive scarring alopecia
that has increased steadily in prevalence since its first description
in 1994. It primarily affects postmenopausal women — presenting as
frontal hairline recession, eyebrow loss, and facial papules. The SOFFIA
2024 international consensus statement (69 experts, 6 continents,
published JEADV July 2025) is the most authoritative current guidance.
The Spanish expert panel (January 2025) recommends avoiding organic
UV filters and benzyl salicylate in cosmetics. The JAAD April 2026
management review outlines current treatment approaches. Here is the
complete honest picture — what FFA is, how it differs from other
scarring alopecias, and the environmental trigger debate.
Azelaic acid and hair loss: what the 2023 minoxidil comparison study found — and the honest gap between interesting evidence and proven treatment.
A 2023 study of 26 women with mild female pattern hair loss compared
5% azelaic acid to 2% topical minoxidil twice daily for six months —
both significantly improved hair density and thickness with no
statistically significant difference between them. A 2015 study found
minoxidil plus azelaic acid plus tretinoin outperformed minoxidil alone.
The honest picture: the mechanism traces to a 1988 in vitro study,
human trials are small, and azelaic acid is not a licensed hair loss
treatment. A 2026 clinical trial is now testing it specifically for
CCCA. Here is the complete evidence review.
What nobody tells you about the patience that hair recovery actually requires.
Three months.
That is how long the telogen phase lasts. Three months between a follicle entering rest and the hair it was holding shedding. Thre...
How to actually read a hair care ingredient label — the INCI system, what the order means, what to avoid, and why "natural" means nothing.
Every hair care product is required to list its ingredients by
concentration — highest to lowest — using the INCI (International
Nomenclature Cosmetic Ingredient) system. The first five ingredients
make up the majority of the formula. "Natural" is unregulated and
meaningless. "Sulfate-free" doesn't mean fragrance-free or paraben-free.
Fragrance can legally hide dozens of undisclosed compounds. This article
is the two-minute guide to reading any hair care label with confidence —
what the system is, what to look for, what to avoid, and the six
marketing claims that tell you nothing.
Hair loss in your 20s and 30s: why it is happening earlier than expected — and the four causes most likely to be driving it.
A 2024-2025 study of 390 AGA patients found mean onset age was
23.9 years in men and 29.46 years in women. 25% of men show
first signs before age 21. Over 10% of premenopausal women
show pattern hair loss evidence before 40. Early-onset hair
loss in the 20s and 30s has four primary drivers — early-onset
AGA, telogen effluvium from nutritional deficiency or stress,
PCOS-driven androgenic loss, and traction alopecia. Each has
a different investigation and approach. The earlier the correct
driver is identified, the more follicles can be preserved.